Detalhe da pesquisa
1.
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Invest New Drugs
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842657
2.
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma.
Liver Int
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838097
3.
Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res
; 53(12): 1213-1223, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574654
4.
Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol
; 38(10): 1743-1749, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221601
5.
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Lab Invest
; 102(3): 281-289, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732847
6.
Serum levels of immunoglobulin M-free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Hepatol Res
; 52(12): 998-1008, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939571
7.
Real-world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
Hepatol Res
; 52(10): 859-871, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921253
8.
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-ß1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Int J Mol Sci
; 22(24)2021 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948151
9.
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma.
Cancer Sci
; 111(10): 3759-3769, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716114
10.
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Liver Int
; 40(7): 1686-1692, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342668
11.
Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study.
Hepatol Res
; 50(12): 1328-1336, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926754
12.
Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes.
Hepatol Res
; 50(7): 831-839, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32337818
13.
A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial.
Support Care Cancer
; 28(6): 2563-2569, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31494734
14.
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
J Hepatol
; 71(3): 543-552, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176752
15.
Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease.
Hepatol Res
; 49(6): 627-636, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716793
16.
Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB-4 index.
Hepatol Res
; 49(4): 473-478, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30549372
17.
FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 21(1)2019 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881781
18.
Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma.
Cancer Sci
; 109(8): 2549-2557, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856900
19.
Impact of Insufficient Response with an Increase in Tumor Number in Predicting Transcatheter Arterial Chemoembolization Refractoriness for Hepatocellular Carcinoma.
Dig Dis
; 36(5): 385-394, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29969764
20.
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease.
Hepatol Res
; 48(3): E42-E51, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28628263